[ad_1]
JHVEPhoto/iStock Editorial via Getty Images
A major cyberattack, a beleaguered pharmacy benefits manager, rising medical expenses, and an executive killing marked a tumultuous year for UnitedHealth Group (NYSE:UNH). Then came the company’s Q4 revenue miss, which sent the managed care firm’s shares into a tailspin
[ad_2]
[ad_1] Exxon asks Texas agency not to disclose agreement terms for carbon capture project [ad_2]
[ad_1] Agree Realty guides for $1.1B-$1.3B of investment volume in 2025 [ad_2]
[ad_1] Gilead upgraded by Morgan Stanley on lenacapavir potential [ad_2]
[ad_1] Euro markets trade at a much larger discount the U.S. [ad_2]
[ad_1] Royal Bank of Canada to partner with Cohere for deployment of AI solution [ad_2]
[ad_1] Ryde bounces off recent low after license renewal [ad_2]